Characteristics of patients administered a 25 versus 50 mg dose of rectal diclofenac after ERCP
| Rectal diclofenac | |||||||
|---|---|---|---|---|---|---|---|
| Total | 25 mg | 50 mg | p Value | ||||
| Men, % (n/N) | 54.8 | (85/155) | 46.4 | (39/84) | 64.8 | (46/71) | 0.022 |
| Age (years), median (IQR) | 71.0 (63.0–76.0) | 73.5 (68.0–80.0) | 67.0 (57.0–74.0) | <0.001 | |||
| Elderly aged ≥65, % (n/N) | 71.0 | (110/155) | 82.1 | (69/84) | 57.7 | (41/71) | 0.001 |
| BMI (kg/m2), median (IQR) | 22.5 (19.5–25.3) | 23.2 (21.2–25.6) | 21.9 (19.2–24.4) | 0.019 | |||
| BMI <22 | 59.6 | (90/151) | 50.0 | (40/80) | 70.4 | (50/71) | 0.011 |
| Cancer, % (n/N) | 32.9 | (50/155) | 34.1 | (28/82) | 31.4 | (22/70) | 0.722 |
| History of pancreatitis, % (n/N) | 16.2 | (25/154) | 13.3 | (11/83) | 19.7 | (14/71) | 0.278 |
| First conducted ERCP, % (n/N) | 34.8 | (54/155) | 33.3 | (28/84) | 36.6 | (26/71) | 0.669 |
| Resident as a main operator, % (n/N) | 63.9 | (99/155) | 71.4 | (60/84) | 54.9 | (39/71) | 0.033 |
| Serum creatinine before ERCP (mg/dL) | 0.80 (0.70–0.90) | 0.80 (0.70–0.90) | 0.80 (0.70–1.00) | 0.642 | |||
| Duration of examination, median (IQR) | 36.5 (26.0–51.3) | 37.0 (28.0–50.0) | 35.0 (23.0–53.0) | 0.568 | |||
| Duration of examination >30 min, % (n/N) | 63.6 | (98/154) | 66.3 | (55/83) | 60.6 | (43/71) | 0.463 |
| Difficult cannulation, % (n/N) | 28.4 | (44/155) | 27.4 | (23/84) | 29.6 | (21/71) | 0.763 |
| Procedures for pancreatic duct, % (n/N) | 68.4 | (106/155) | 69.0 | (58/84) | 67.6 | (48/71) | 0.847 |
| Pancreatic duct wire, % (n/N) | 65.2 | (101/155) | 65.5 | (55/84) | 64.8 | (46/71) | 0.929 |
| Cytology of pancreas duct, % (n/N) | 19.4 | (30/155) | 17.9 | (15/84) | 21.1 | (15/71) | 0.608 |
| Pancreatography, % (n/N) | 31.6 | (49/155) | 34.5 | (29/84) | 28.2 | (20/71) | 0.397 |
| Cytology of bile duct, % (n/N) | 18.7 | (29/155) | 20.2 | (17/84) | 16.9 | (12/71) | 0.596 |
| EST, % (n/N) | 26.5 | (41/155) | 23.8 | (20/84) | 29.6 | (21/71) | 0.417 |
| EPBD, % (n/N) | 5.8 | (9/155) | 6.0 | (5/84) | 5.6 | (4/71) | 0.605 |
| Choledocholithotomy, % (n/N) | 38.1 | (59/155) | 41.7 | (35/84) | 33.8 | (24/71) | 0.315 |
| Stenting to pancreatic duct, % (n/N) | 2.6 | (4/155) | 2.4 | (2/84) | 2.8 | (2/71) | 0.624 |
BMI, body mass index; EPBD, endoscopic papillary balloon dilation; ERCP, endoscopic retrograde cholangiopancreatography; EST, endoscopic sphincterotomy.